Do, K., Wilsker, D., Ji, J., Zlott, J., Freshwater, T., Kinders, R. J., . . . Kummar, S. (2015). Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors. J Clin Oncol.
Chicago-стиль цитированияDo, Khanh, et al. "Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors." J Clin Oncol 2015.
MLA-цитированиеDo, Khanh, et al. "Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors." J Clin Oncol 2015.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.